CD274 and neoplasm: Patients demonstrating combined PD-L1+ tumour cells and intense reaction of PD-L1+ non-neoplastic cells (high PD-L1+ group) showed significantly poorer prognosis compared with the low PD-L1+ group in the above four types of PTCLs [18].